Christine Hafner Selected Research

HMW-MAA

12/2008	Reduction of human melanoma tumor growth in severe combined immunodeficient mice by passive transfer of antibodies induced by a high molecular weight melanoma-associated antigen mimotope vaccine.
7/2005	High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells.
4/2005	Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody.
4/2005	Cross-reactivity of mimotopes with a monoclonal antibody against the high molecular weight melanoma-associated antigen (HMW-MAA) does not predict cross-reactive immunogenicity.
1/2005	Vaccination with a human high molecular weight melanoma-associated antigen mimotope induces a humoral response inhibiting melanoma cell growth in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christine Hafner Research Topics

Disease

14	Melanoma (Melanoma, Malignant) 09/2022 - 10/2002
11	Neoplasms (Cancer) 09/2021 - 01/2005
8	Hypersensitivity (Allergy) 01/2021 - 01/2011
6	Peanut Hypersensitivity (Peanut Allergy) 01/2021 - 07/2013
2	Neoplasm Metastasis (Metastasis) 09/2022 - 01/2016
2	Seasonal Allergic Rhinitis (Hay Fever) 01/2019 - 01/2015
2	Hypoxia (Hypoxemia) 04/2016 - 07/2015
1	Brain Neoplasms (Brain Tumor) 09/2022
1	Hemorrhage 09/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2021
1	Glioma (Gliomas) 09/2021
1	Breast Neoplasms (Breast Cancer) 09/2021
1	Anaphylaxis (Anaphylactic Shock) 01/2020
1	Blister (Bulla) 01/2019
1	Leukemia 01/2017
1	Latex Hypersensitivity (Latex Allergy) 01/2011

Drug/Important Bio-Agent (IBA)

10	Immunoglobulin E (IgE)IBA 01/2021 - 01/2011
7	AllergensIBA 01/2021 - 01/2011
5	AntibodiesIBA 01/2021 - 07/2005
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2005
5	EpitopesIBA 01/2020 - 10/2002
5	VaccinesIBA 01/2017 - 01/2005
5	HMW-MAAIBA 12/2008 - 01/2005
4	hypoxanthine arabinoside (ara-H)IBA 01/2020 - 07/2013
3	Monoclonal AntibodiesIBA 09/2021 - 10/2002
3	VemurafenibIBA 09/2021 - 07/2015
3	Phosphotransferases (Kinase)IBA 01/2021 - 07/2015
3	ParvalbuminsIBA 01/2019 - 01/2015
3	Indicators and Reagents (Reagents)IBA 10/2016 - 04/2005
2	Chondroitin Sulfate ProteoglycansIBA 09/2021 - 07/2015
2	Chondroitin Sulfates (Chondroitin Sulfate)IBA 09/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 07/2015
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2017
2	Carbonic Anhydrase IXIBA 04/2016 - 07/2015
2	Immunoglobulin G (IgG)IBA 07/2013 - 12/2008
2	Peptides (Polypeptides)IBA 04/2005 - 10/2002
1	HemosiderinIBA 09/2022
1	Melanins (Melanin)IBA 09/2022
1	AcidsIBA 09/2022
1	Proteoglycans (Proteoglycan)IBA 01/2021
1	talimogene laherparepvecIBA 01/2021
1	LeguminsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019
1	Interleukin-3 (Interleukin 3)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Protein Kinases (Protein Kinase)IBA 04/2016
1	Janus KinasesIBA 04/2016
1	Cadherins (E-Cadherin)IBA 01/2016
1	chondroitin sulfate proteoglycan 4IBA 07/2015
1	Neoplasm Antigens (Tumor Antigens)IBA 07/2015
1	tyrosine receptor (receptor, tyrosine)IBA 07/2015
1	CalciumIBA 01/2015
1	LatexIBA 01/2011
1	ChitinasesIBA 01/2011
1	heveinIBA 01/2011
1	AntigensIBA 04/2005
1	Biological ProductsIBA 01/2005
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 10/2002

Therapy/Procedure

5	Therapeutics 01/2021 - 04/2005
4	Immunotherapy 01/2020 - 01/2005
1	Injections 01/2021
1	Subcutaneous Injections 04/2005
1	Radiotherapy 01/2005
1	Drug Therapy (Chemotherapy) 01/2005